BOHLIN GAREN G 4
4 · Karyopharm Therapeutics Inc. · Filed May 25, 2023
Insider Transaction Report
Form 4
BOHLIN GAREN G
Director
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2023-05-24+34,000→ 34,000 totalExercise: $2.50Exp: 2033-05-23→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]This option vests as to 100% of the underlying shares on May 24, 2024.